Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.

@article{Ruotolo2000SerumIG,
  title={Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.},
  author={Giacomo Ruotolo and Peter N B{\aa}venholm and Kerstin E Brismar and Suad Efend{\'i}c and Christina Ericsson and Ulf H de Faire and J. W. Nilsson and Anders Hamsten},
  journal={Journal of the American College of Cardiology},
  year={2000},
  volume={35 3},
  pages={647-54}
}
OBJECTIVES We investigated whether the effect of bezafibrate on progression of coronary atherosclerosis in the BEzafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) was related to insulin-like growth factor (IGF)-I and glucose-insulin homeostasis. BACKGROUND BECAIT, the first double-blind, placebo-controlled, randomized, serial angiographic… CONTINUE READING